AREVA Med

decorative

About AREVA Med

AREVA Med is an AREVA subsidiary specializing in the development of innovative new therapies to fight cancer.

decorative

How it works

Learn how the nuclear therapy works, what is lead-212 (212Pb), and about our ongoing research.

decorative

Clinical Trials

The Phase I clinical trials of lead-212 is currently taking place in the United States.

decorative

News & Materials

Read about the latest news and events, and download brochures and fact sheets.

decorative

Macrocyclics

Macrocyclics, part of AREVA Med, is the global leader in chelating agent technologies for medicine.

Latest News

AREVA Med selects Caen for its future lead-212 production facility

02/12/2014

AREVA Med selects Caen for its future lead-212 production facility

Read more
Macrocyclics introduces new products

01/10/2014

Macrocyclics introduces new products

Read more
AREVA Med launches production of lead-212 at new facility

11/21/2013

AREVA Med launches production of lead-212 at new facility

Read more
Contact

For more information about AREVA Med, please contact:
Alison Tise
Tel.: + 1 (301) 841-1673

Contact

For more information about Macrocyclics, please contact:

Garry Kiefer

Tel.: + 1 (972) 250-2248

Linked In
decorative

Follow AREVA Med on

Twitter
decorative

Follow @AREVAmed on

Join Our Team!
decorative

AREVA Med is seeking a laboratory technician for our facility in Bessines, Limousin, France.  For a complete job listing, please visit